Olmesartan Krka (Olmesartan Medoxomil)

Olmesartan medoxil, the active ingredient in Olmesartan Krka, is an angiotensin II receptor blocker presented as a tablet for oral use. It is used to manage high blood pressure in adult patients. GNH USA supplies Olmesartan Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartan Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan medoxil is an angiotensin II receptor blocker that helps control blood pressure and related cardiovascular conditions.

- Hypertension: Lowers systolic and diastolic blood pressure, reducing risk of stroke and heart attack. - Heart failure: Assists in managing fluid overload and improves cardiac output. - Diabetic nephropathy: Slows progression of kidney damage associated with diabetes.

Olmesartan medoxil may cause several adverse reactions, most of which are mild and transient.

Common Side Effects: - Dizziness - Headache - Fatigue - Nasal congestion - Diarrhea - Cough

Serious or Rare Side Effects: - Angio‑angry  - Hyper‑hyper  - Severe hypotension - Acute kidney injury - Liver enzyme elevation - Blood cell 

Olmesartan medoxil should be used cautiously when:

- Monitor "); -  ");  - ");  -  -  - Store ");

The 

   """""  "" """"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""